Yuma Yokoi

845 total citations
33 papers, 602 citations indexed

About

Yuma Yokoi is a scholar working on Psychiatry and Mental health, Neurology and Cognitive Neuroscience. According to data from OpenAlex, Yuma Yokoi has authored 33 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 13 papers in Neurology and 11 papers in Cognitive Neuroscience. Recurrent topics in Yuma Yokoi's work include Transcranial Magnetic Stimulation Studies (12 papers), Alzheimer's disease research and treatments (9 papers) and Dementia and Cognitive Impairment Research (7 papers). Yuma Yokoi is often cited by papers focused on Transcranial Magnetic Stimulation Studies (12 papers), Alzheimer's disease research and treatments (9 papers) and Dementia and Cognitive Impairment Research (7 papers). Yuma Yokoi collaborates with scholars based in Japan, United States and Sweden. Yuma Yokoi's co-authors include Tomiki Sumiyoshi, Zui Narita, Harumasa Takano, Miho Ota, Kazushi Maruo, Takeshi Takahashi, Ikki Ishida, Junko Matsuo, Sumiko Yoshida and Hiroshi Kunugi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Journal of Affective Disorders.

In The Last Decade

Yuma Yokoi

31 papers receiving 598 citations

Peers

Countries citing papers authored by Yuma Yokoi

Since Specialization

Citations

This map shows the geographic impact of Yuma Yokoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuma Yokoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuma Yokoi more than expected).

Fields of papers citing papers by Yuma Yokoi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuma Yokoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuma Yokoi. The network helps show where Yuma Yokoi may publish in the future.

Co-authorship network of co-authors of Yuma Yokoi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuma Yokoi. A scholar is included among the top collaborators of Yuma Yokoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuma Yokoi. Yuma Yokoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease 2025 ·JAMA Neurology ·Ming Lu, (unknown), Emily C. Collins, Sergey Shcherbinin, (unknown), Yuma Yokoi, Dawn A. Brooks, Oskar Hansson, David S. Knopman, John R. Sims, Mark A. Mintun	2
2	Assessment of Gray Matter Microstructural Alterations in Alzheimer’s Disease by Free Water Imaging 2024 ·Journal of Alzheimer s Disease ·Moto Nakaya, Noriko Sato, Hiroshi Matsuda, Norihide Maikusa, Miho Ota, Yoko Shigemoto, Daichi Sone, Tensho Yamao, Yukio Kimura, Tadashi Tsukamoto, Yuma Yokoi, Masuhiro Sakata, Osamu Abe	4
3	A randomized sham-controlled trial of transcranial and intranasal photobiomodulation in Japanese patients with mild cognitive impairment and mild dementia due to Alzheimer’s disease: a protocol 2024 ·Frontiers in Neurology ·Yuma Yokoi, Takuma Inagawa, Yuji Yamada, (unknown), (unknown), Takamasa Noda	0
4	Pathogenic Potential of Eomesodermin‐Expressing T‐Helper Cells in Neurodegenerative Diseases 2024 ·Annals of Neurology ·(unknown), Wakiro Sato, Ben J. E. Raveney, (unknown), (unknown), Hiromi Yamaguchi, Yuma Yokoi, (unknown), Yuji Takahashi, Tsuneo Fujita, Shinji Saiki, Akira Tamaoka, Shinji Oki, Takashi Yamamura	3
5	Depression and suicidality with VMAT2 inhibitors in tardive dyskinesia A signal detection from the FDA Adverse Events Reporting System 2023 ·SHILAP Revista de lepidopterología ·Yuma Yokoi, Hiroko Kashiwagi, (unknown), (unknown), Chika Kubota	0
6	Electrode montage for transcranial direct current stimulation governs its effect on symptoms and functionality in schizophrenia 2023 ·Frontiers in Psychiatry ·Yuji Yamada, Zui Narita, Takuma Inagawa, Yuma Yokoi, Naotsugu Hirabayashi, (unknown), (unknown), (unknown)	2
7	Relationship between the tau protein and choroid plexus volume in Alzheimer’s disease 2023 ·Neuroreport ·Miho Ota, Noriko Sato, Moto Nakaya, Yoko Shigemoto, Yukio Kimura, (unknown), Yuma Yokoi, Tadashi Tsukamoto, Hiroshi Matsuda	10
8	Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis 2023 ·Schizophrenia Research Cognition ·(unknown), (unknown), Andrew Stickley, Yuma Yokoi, Tomiki Sumiyoshi	5
9	Free water derived by multi‐shell diffusion MRI reflects tau/neuroinflammatory pathology in Alzheimer's disease 2022 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Moto Nakaya, Noriko Sato, Hiroshi Matsuda, Norihide Maikusa, Yoko Shigemoto, Daichi Sone, Tensho Yamao, Masayo Ogawa, Yukio Kimura, (unknown), Masahiro Ohnishi, Koichi Kato, Kyoji Okita, Tadashi Tsukamoto, Yuma Yokoi, Masuhiro Sakata, Osamu Abe	24
10	Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer’s Disease: Diffusion Tensor Image Study 2022 ·Journal of Alzheimer s Disease ·Miho Ota, Noriko Sato, Moto Nakaya, Yoko Shigemoto, Yukio Kimura, (unknown), Yuma Yokoi, Tadashi Tsukamoto, Hiroshi Matsuda	52
11	Transcranial Direct Current Stimulation on the Left Superior Temporal Sulcus Improves Social Cognition in Schizophrenia: An Open-Label Study 2022 ·Frontiers in Psychiatry ·Yuji Yamada, (unknown), Yuma Yokoi, Takuma Inagawa, Naotsugu Hirabayashi, (unknown), (unknown), Tomiki Sumiyoshi	10
12	Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: A randomized, parallel-group, non-inferiority trial 2021 ·Journal of Affective Disorders ·Kazuyuki Nakagome, Yuma Yokoi, Atsuo Nakagawa, Masayuki Tani, (unknown), Naoki Yoshimura, Toshi A. Furukawa, Koichiro Watanabe, Masaru Mimura, Akira Iwanami, Takayuki Abe	2
13	Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second‐generation antidepressants: Study protocol for a randomized, parallel‐group, non‐inferiority trial 2019 ·Neuropsychopharmacology Reports ·Yuma Yokoi, Atsuo Nakagawa, Naoki Yoshimura, Toshi A. Furukawa, Masaru Mimura, Akira Iwanami, Takayuki Abe, Kazuyuki Nakagome	3
14	Effect of multi-session prefrontal transcranial direct current stimulation on cognition in schizophrenia: A systematic review and meta-analysis 2019 ·Schizophrenia Research ·Zui Narita, Andrew Stickley, Jordan DeVylder, Yuma Yokoi, Takuma Inagawa, Yuji Yamada, Kazushi Maruo, Ai Koyanagi, Hans Oh, Akira Sawa, Tomiki Sumiyoshi	38
15	Safety and Feasibility of Transcranial Direct Current Stimulation for Cognitive Rehabilitation in Patients With Mild or Major Neurocognitive Disorders: A Randomized Sham-Controlled Pilot Study 2019 ·Frontiers in Human Neuroscience ·Takuma Inagawa, Yuma Yokoi, Zui Narita, Kazushi Maruo, Mitsutoshi Okazaki, Kazuyuki Nakagome	20
16	Discrete effect of each mild behavioural impairment category on dementia conversion or cognitive decline in patients with mild cognitive impairment 2019 ·Psychogeriatrics ·Yuma Yokoi, Harumasa Takano, Masuhiro Sakata, Kazushi Maruo, Kazuyuki Nakagome, Hiroshi Matsuda	20
17	Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer’s Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study 2018 ·Frontiers in Aging Neuroscience ·Yoko Shigemoto, Daichi Sone, Etsuko Imabayashi, Norihide Maikusa, Nobuyuki Okamura, Shozo Furumoto, Yukitsuka Kudo, Masayo Ogawa, Harumasa Takano, Yuma Yokoi, Masuhiro Sakata, Tadashi Tsukamoto, Koichi Kato, Noriko Sato, Hiroshi Matsuda	12
18	A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson’s disease 2018 ·BMC Psychiatry ·Naomi Kokubo, Yuma Yokoi, Yuji Saitoh, Miho Murata, Kazushi Maruo, Yoshitake Takebayashi, (unknown), (unknown), Masaru Horikoshi	16
19	Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease 2018 ·Neuroscience Letters ·Miho Ota, Junko Matsuo, Ikki Ishida, Harumasa Takano, Yuma Yokoi, Hiroaki Hori, Sumiko Yoshida, Kinya Ashida, Kentaro Nakamura, Takeshi Takahashi, Hiroshi Kunugi	200
20	Transcranial direct current stimulation for depression in Alzheimer’s disease: study protocol for a randomized controlled trial 2017 ·Trials ·Zui Narita, Yuma Yokoi	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact